FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285804468> ?p ?o ?g. }

• W4285804468 endingPage "669" @default.
• W4285804468 startingPage "662" @default.
• W4285804468 abstract "SIGNIFICANCE Severe vision loss from Bartonella neuroretinitis can be best treated to improve visual outcomes with a combination of systemic corticosteroids and antibiotics. Topical ketorolac 0.5% and difluprednate 0.05% are presented as a new adjunct therapy to potentially improve visual outcomes. PURPOSE This case illustrates severe posterior pole complications that can occur with cat scratch disease disseminated to the eye. Combination therapy with antibiotics and corticosteroids results in better visual outcomes. Topical treatment might further enhance visual outcome by preventing inflammatory damage without significant immunosuppression. CASE REPORT A 17-year-old male teenager presented with right eye vision loss. He had been hospitalized 2 weeks prior for optic neuritis and treated with intravenous methylprednisolone. After 3 days, vision had improved from 20/200 to 20/40. After positive serology for Bartonella henselae was obtained, he was released and treated with oral rifampin, doxycycline, and prednisone. Sixteen days later, he regressed to 20/200, and many more ophthalmic complications were observed. After discontinuation of rifampin, oral prednisone was continued for an additional 2 weeks, and doxycycline was continued for approximately 3 weeks. Topical drops ketorolac 0.5% twice a day and difluprednate 0.05% four times a day were used for more than 6 weeks before tapering after vision returned to normal. CONCLUSIONS Bartonella neuroretinitis associated with pre-retinal hemorrhage, vitritis, and subretinal hemorrhage can be successfully treated with a combination of systemic medications and topical drops. Monotherapy with doxycycline is effective and well tolerated. Rifampin can cause rapid metabolization and reduction in plasma levels of both prednisone and doxycycline and should be avoided with combined therapy. Oral prednisone and topical difluprednate are recommended to quell initial inflammation during the first few weeks. The anti-inflammatory effects of doxycycline and topical ketorolac used for longer duration may be beneficial in preventing tissue damage without systemic immunosuppression and result in better visual outcomes." @default.
• W4285804468 created "2022-07-19" @default.
• W4285804468 creator A5024430656 @default.
• W4285804468 date "2022-07-14" @default.
• W4285804468 modified "2023-09-27" @default.
• W4285804468 title "Case Report: Treatment of Severe Neuroretinitis and other Sequelae Associated with Cat Scratch Disease" @default.
• W4285804468 cites W1838067808 @default.
• W4285804468 cites W1985921160 @default.
• W4285804468 cites W2007148659 @default.
• W4285804468 cites W2008202406 @default.
• W4285804468 cites W2035147444 @default.
• W4285804468 cites W2044523314 @default.
• W4285804468 cites W2051852607 @default.
• W4285804468 cites W2053440887 @default.
• W4285804468 cites W2064199492 @default.
• W4285804468 cites W2073257242 @default.
• W4285804468 cites W2076435955 @default.
• W4285804468 cites W2080524229 @default.
• W4285804468 cites W2090917129 @default.
• W4285804468 cites W2118874922 @default.
• W4285804468 cites W2123903109 @default.
• W4285804468 cites W2159165131 @default.
• W4285804468 cites W2168064859 @default.
• W4285804468 cites W2222018504 @default.
• W4285804468 cites W2334586896 @default.
• W4285804468 cites W2518847284 @default.
• W4285804468 cites W2793153110 @default.
• W4285804468 cites W2889321438 @default.
• W4285804468 cites W2954609420 @default.
• W4285804468 cites W3021992663 @default.
• W4285804468 cites W3035037094 @default.
• W4285804468 cites W3089548128 @default.
• W4285804468 cites W3090760564 @default.
• W4285804468 cites W4230553370 @default.
• W4285804468 cites W4361741391 @default.
• W4285804468 doi "https://doi.org/10.1097/opx.0000000000001922" @default.
• W4285804468 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35849047" @default.
• W4285804468 hasPublicationYear "2022" @default.
• W4285804468 type Work @default.
• W4285804468 citedByCount "1" @default.
• W4285804468 countsByYear W42858044682022 @default.
• W4285804468 crossrefType "journal-article" @default.
• W4285804468 hasAuthorship W4285804468A5024430656 @default.
• W4285804468 hasConcept C118487528 @default.
• W4285804468 hasConcept C126322002 @default.
• W4285804468 hasConcept C141071460 @default.
• W4285804468 hasConcept C159654299 @default.
• W4285804468 hasConcept C16005928 @default.
• W4285804468 hasConcept C203014093 @default.
• W4285804468 hasConcept C2522874641 @default.
• W4285804468 hasConcept C2777016524 @default.
• W4285804468 hasConcept C2777179404 @default.
• W4285804468 hasConcept C2777534959 @default.
• W4285804468 hasConcept C2777535154 @default.
• W4285804468 hasConcept C2778257484 @default.
• W4285804468 hasConcept C2778715236 @default.
• W4285804468 hasConcept C2778720950 @default.
• W4285804468 hasConcept C2779134260 @default.
• W4285804468 hasConcept C2779820661 @default.
• W4285804468 hasConcept C45189115 @default.
• W4285804468 hasConcept C501593827 @default.
• W4285804468 hasConcept C71924100 @default.
• W4285804468 hasConcept C86803240 @default.
• W4285804468 hasConcept C89423630 @default.
• W4285804468 hasConceptScore W4285804468C118487528 @default.
• W4285804468 hasConceptScore W4285804468C126322002 @default.
• W4285804468 hasConceptScore W4285804468C141071460 @default.
• W4285804468 hasConceptScore W4285804468C159654299 @default.
• W4285804468 hasConceptScore W4285804468C16005928 @default.
• W4285804468 hasConceptScore W4285804468C203014093 @default.
• W4285804468 hasConceptScore W4285804468C2522874641 @default.
• W4285804468 hasConceptScore W4285804468C2777016524 @default.
• W4285804468 hasConceptScore W4285804468C2777179404 @default.
• W4285804468 hasConceptScore W4285804468C2777534959 @default.
• W4285804468 hasConceptScore W4285804468C2777535154 @default.
• W4285804468 hasConceptScore W4285804468C2778257484 @default.
• W4285804468 hasConceptScore W4285804468C2778715236 @default.
• W4285804468 hasConceptScore W4285804468C2778720950 @default.
• W4285804468 hasConceptScore W4285804468C2779134260 @default.
• W4285804468 hasConceptScore W4285804468C2779820661 @default.
• W4285804468 hasConceptScore W4285804468C45189115 @default.
• W4285804468 hasConceptScore W4285804468C501593827 @default.
• W4285804468 hasConceptScore W4285804468C71924100 @default.
• W4285804468 hasConceptScore W4285804468C86803240 @default.
• W4285804468 hasConceptScore W4285804468C89423630 @default.
• W4285804468 hasIssue "8" @default.
• W4285804468 hasLocation W42858044681 @default.
• W4285804468 hasLocation W42858044682 @default.
• W4285804468 hasOpenAccess W4285804468 @default.
• W4285804468 hasPrimaryLocation W42858044681 @default.
• W4285804468 hasRelatedWork W2062437977 @default.
• W4285804468 hasRelatedWork W2091523747 @default.
• W4285804468 hasRelatedWork W2396746280 @default.
• W4285804468 hasRelatedWork W3104128500 @default.
• W4285804468 hasRelatedWork W3120169153 @default.
• W4285804468 hasRelatedWork W3193644264 @default.
• W4285804468 hasRelatedWork W4234510544 @default.
• W4285804468 hasRelatedWork W4300981303 @default.

• next